Last $4.36 USD
Change Today -0.06 / -1.36%
Volume 449.5K
CYTK On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Schmertzler

Chairman of the Board of Directors, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, PTC Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 7 different industries.

See Board Relationships
62$781,007

Background*

Mr. Michael Schmertzler was Co-Founder of Kolltan Pharmaceuticals, Inc. and served as its Chief Executive Officer. Mr. Schmertzler serves at American Express Company and Morgan Stanley. Mr. Schmertzler served as Managing Director of Aries Advisors LLC, a sub-advisor to Credit Suisse First Boston Equity Partners LP since 2001. Mr. Schmertzler served as Co-Head at Credit Suisse First Boston's Private Equity Partners, LP and Credit Suisse First Boston Equity Partners (Bermuda), ...

Read Full Background

Corporate Headquarters*

280 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-624-3000
Fax: 650-624-3010

Board Members Memberships*

Former Director
Former Director
Director
Co-Founder
1992-N/A
Director
2001-Present
Chairman of the Board of Directors, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2003-2010
Former Independent Director and Member of Compensation & Talent Committee

Education*

MBA
Harvard Business School
BA1993 - 1997
Yale College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$23,819
Total Calculated Compensation$781,007
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTK:US $4.36 USD -0.06

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOKINETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.